This Promising New Alzheimer's Study Could Unlock a Massive Growth Opportunity for Novo Nordisk and Eli Lilly
Eli Lilly ( LLY 1.07%) and Novo Nordisk ( NVO -1.99%) are two of the most valuable healthcare stocks in the world, largely ...
How a Common Virus Could Trigger Alzheimer’s Disease
Researchers have linked herpes simplex virus-1 with Alzheimer's disease, revealing a surprising potential viral trigger for the neurodegenerative condition. Their study suggests that the tau protein, ...
Head injuries may reactivate herpes virus in brain, raise Alzheimer's risk: Study
A recent study by Tufts and Oxford universities reveals that head trauma can activate dormant herpes viruses in the brain, ...
Johnson & Johnson Gets FDA Fast-Track Designation for Posdinemab in Alzheimer's
The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...
Johnson & Johnson's Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer's Disease
Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to posdinemab, a phosphorylated tau-directed monoclonal antibody (mAb) ...
Viruses living your brain may 'wake up' to cause dementia, say experts
Studies have long warned that blows to the head may raise the risk of neurodegenerative conditions. Now, scientists believe ...
IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer’s Agitation “CALMA” and Expands Recruitment Strategy
POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...
LETTERS: Impact of predators; Lamborn's Alzheimer's efforts
As Lamborn prepares to leave office, we are most grateful for his support. His support of these signed bills advances the ...
Why Alzheimer’s Scientists Are Re-thinking the Amyloid Hypothesis
For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...
The Daily Northwestern10h
Northwestern Researchers look into SuperAgers at the Mesulam Center
Physicians diagnose around 40% of those over the age of 90 with Alzheimer’s disease, according to Robert Vassar, director of Northwestern’s Mesulam Center for Cognitive Neurology and Alzheimer’s ...
healthday14h
More Evidence Bolsters the Oral Herpes and Alzheimer’s Link
That cold sore on your lip might be painful and unsightly, but it could also be a harbinger of debilitating brain agin ...
Science Daily16h
Study challenges traditional risk factors for brain health in the oldest-old
A study has found cardiovascular conditions such as high blood pressure and diabetes, which are known to contribute to brain blood vessel damage in younger populations, not to be associated with an ...